The Case of Medication-Related Osteonecrosis of the Jaw Addressed from a Pathogenic Point of View. Innovative Therapeutic Strategies: Focus on the Most Recent Discoveries on Oral Mesenchymal Stem Cell-Derived Exosomes

Bisphosphonates-related osteonecrosis of the jaw (BRONJ) was firstly reported by Marx in 2003. Since 2014, the term medication-related osteonecrosis of the jaw (MRONJ) is recommended by the American Association of Oral and Maxillofacial Surgeons (AAOMS). Development of MRONJ has been associated to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Giudice, Amerigo, Antonelli, Alessandro, Chiarella, Emanuela, Baudi, Francesco, Barni, Tullio, Di Vito, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760182/
https://www.ncbi.nlm.nih.gov/pubmed/33255626
http://dx.doi.org/10.3390/ph13120423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760182/
https://www.ncbi.nlm.nih.gov/pubmed/33255626
http://dx.doi.org/10.3390/ph13120423

Ejemplares similares